This study investigates pancreatic cancer. The purpose is to assess early detection methods using liquid biopsy techniques.
This study evaluates the effectiveness of various biomarker assays, including cfDNA methylation and circulating tumor DNA mutation, for detecting pancreatic cancer. The purpose of this study is to understand how these markers can be used together to identify the disease at an early stage.
- Who can participate: Participants aged 40 to 75 years old who can provide written consent and qualified blood samples are eligible.
- Study details: Participants will provide blood samples for testing.